Research Article

Low Expression of p53 in Sacrouterine Ligament as A Risk Factor for Stage III-IV Uterine Prolapse

Dewa Gede Sidan Pradnyandita
Sanglah General Hospital, Indonesia
* Corresponding author
I Wayan Megadhana
Udayana University, Indonesia
Ketut Suwiyoga
Udayana University, Indonesia
I Made Darmayasa
Udayana University, Indonesia
Anom Suardika
Udayana University, Indonesia
Endang Sri Widiyanti
Udayana University, Indonesia
DOI icon 10.24018/ejmed.2022.4.5.1461

Read Counter
603

Downloads
330

Citations

Share

Article Sidebar

Submitted 2022-08-01
Published 2022-10-22

Read counter = 603 times

Table of Contents

Article Main Content

Introduction: As life expectancy increases, so does the incidence of pelvic organ prolapse (POP). Low expression of p53 may lead to reduced production and deposition of elastin in the extracellular matrix thus it may increase the risk for POP. This study aims to determine the relationship between p53 expression and the incidence of grade III-IV POP.

Methods: This observational case-control study involved women with grade III-IV POP that underwent a total hysterectomy at Sanglah General Hospital Denpasar as the case group. The control group was non-prolapsed women who were matched to the case for the variables of age, parity, body mass index (BMI), and occupation to minimize bias. The p53 expression was grouped into low (<146.90) and high (≥146.90) expressions according to the optimal cut-off value obtained from the receiver operating characteristic curve. Bivariate analysis between p53 expression and risk of POP was performed using the Chi-square test.

Results: A total of 44 patients were included in this study with 22 patients with grade III-IV POP and 22 patients without POP. There were no significant differences in age, parity, BMI, and occupation between the two groups. Low p53 expression increased the risk of stage III-IV uterine prolapse by 20.25 times higher (OR = 20.25; 95% CI = 4.375-93.722; p = 0.000).

Conclusion: The low p53 expression in the sacrouterine ligament is a significant risk factor for grade III and IV POP.

Keywords: Elastin, Grade III-IV uterine prolapse, p53 Expression

References

  1. Herschorn S. Female pelvic floor anatomy: the pelvic floor, supporting structures, and pelvic organs. Rev Urol. 2004; 6 Suppl 5(Suppl 5): S2-S10.
     Google Scholar
  2. Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013; 24(11): 1783-1790.
    DOI  |   Google Scholar
  3. Bradley CS. Progress toward understanding pelvic organ prolapse. Am J Obstet Gynecol. 2018; 218(3): 267-268.
    DOI  |   Google Scholar
  4. Kusuma IGYS, Megaputra IG, Megadhana IW, Sanjaya INH, Manuaba IF. Characteristic of patients with pelvic organ prolapse in obstetric and gynecologic outpatient clinic in Sanglah Hospital, Bali, Indonesia from January 2014 to December 2015. Bali Med J. 2017; 6(1): 76.
    DOI  |   Google Scholar
  5. Kastenhuber ER, Lowe SW. Putting p53 in Context. Cell. 2017; 170(6): 1062-1078.
    DOI  |   Google Scholar
  6. Bai SW, Chung DJ, Yoon JM, Shin JS, Kim SK, Park KH. Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2005; 16(6): 492-496.
    DOI  |   Google Scholar
  7. Connell KA, Guess MK, Chen HW, Lynch T, Bercik R, Taylor HS. HOXA11 promotes fibroblast proliferation and regulates p53 in uterosacral ligaments. Reprod Sci. 2009; 16(7): 694-700.
    DOI  |   Google Scholar
  8. Sayko SK, Kurniawati EM, Lestari P. Age as the risk factor that affected the increased degree of uterine prolapse. Biomol nad Heal Sci J. 2018; 1(1): 20–4.
    DOI  |   Google Scholar
  9. Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020; 46(1): 5-14.
    DOI  |   Google Scholar
  10. Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015; 26(11): 1559-1573.
    DOI  |   Google Scholar
  11. Shrestha B, Onta S, Choulagai B, Paudel R, Petzold M, Krettek A. Uterine prolapse and its impact on quality of life in the Jhaukhel-Duwakot Health Demographic Surveillance Site, Bhaktapur, Nepal. Glob Health Action. 2015; 8: 28771.
    DOI  |   Google Scholar
  12. Putra HK, Aidi CZ, Zulkarnain M. Analysis of Risk Factors with the Degree of Pelvic Organs Prolapse at Dr. Mohammad Hoesin General Hospital Palembang. Biosci Med J Biomed Transl Res. 2021; 5(11): 1005–8.
    DOI  |   Google Scholar
  13. Kuncharapu I, Majeroni BA, Johnson DW. Pelvic organ prolapse. Am Fam Physician. 2010; 81(9): 1111-1117.
     Google Scholar
  14. Quiroz LH, Muñoz A, Shippey SH, Gutman RE, Handa VL. Vaginal parity and pelvic organ prolapse. J Reprod Med. 2010; 55(3-4): 93-98.
     Google Scholar
  15. Blomquist JL, Carroll M, Muñoz A, Handa VL. Pelvic floor muscle strength and the incidence of pelvic floor disorders after vaginal and cesarean delivery. Am J Obstet Gynecol. 2020; 222(1): 62.e1-62.e8.
    DOI  |   Google Scholar
  16. Lee UJ, Kerkhof MH, van Leijsen SA, Heesakkers JP. Obesity and pelvic organ prolapse. Curr Opin Urol. 2017; 27(5): 428-434.
    DOI  |   Google Scholar
  17. Joseph N, Krishnan C, Reddy BA, Adnan NA, Han LM, Min YJ. Clinical Profile of Uterine Prolapse Cases in South India. J Obstet Gynaecol India. 2016; 66(Suppl 1): 428-434.
    DOI  |   Google Scholar
  18. Devkota HR, Sijali TR, Harris C, Ghimire DJ, Prata N, Bates MN. Bio-mechanical risk factors for uterine prolapse among women living in the hills of west Nepal: A case-control study. Womens Health (Lond). 2020; 16: 1745506519895175.
    DOI  |   Google Scholar
  19. Henok A. Prevalence and Factors Associated with Pelvic Organ Prolapse among Pedestrian Back-Loading Women in Bench Maji Zone. Ethiop J Health Sci. 2017; 27(3): 263-272.
    DOI  |   Google Scholar
  20. Yamamoto M, Aoyagi M, Akazawa K, Tajima S, Yamamoto K. Decrease in p53 protein in cultured cardinal ligament fibroblasts from patients with prolapsus uteri. Cell Biol Int. 1998; 22(1): 31-40.
    DOI  |   Google Scholar
  21. Yamamoto M, Akazawa K, Aoyagi M, Yamamoto K. Changes in biological characteristics during the cellular aging of ligament fibroblasts derived from patients with prolapsus uteri. Mech Ageing Dev. 2000; 115(3): 175-187.
    DOI  |   Google Scholar
  22. Couri BM, Lenis AT, Borazjani A, Paraiso MF, Damaser MS. Animal models of female pelvic organ prolapse: lessons learned. Expert Rev Obstet Gynecol. 2012; 7(3): 249-260.
    DOI  |   Google Scholar
  23. Kerkhof MH, Hendriks L, Brölmann HA. Changes in connective tissue in patients with pelvic organ prolapse--a review of the current literature. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20(4): 461-474.
    DOI  |   Google Scholar
  24. Megadhana IW, Suwiyoga K. Stage III-IV uterine prolapse risk factors: sacrouterine ligaments high estrogen receptor alpha and collagen III expression and low elastin expression. Bali Med J. 2016; 5(1): 91–7.
    DOI  |   Google Scholar
  25. Tracy LE, Minasian RA, Caterson EJ. Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. Adv Wound Care (New Rochelle). 2016; 5(3): 119-136.
    DOI  |   Google Scholar
  26. Lammers K, Lince SL, Spath MA, van Kempen LC, Hendriks J, Vierhout ME, et al. Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J. 2012; 23(3): 313-319.
    DOI  |   Google Scholar


Most read articles by the same author(s)

<< < 1 2 3